A combination of benznidazole and ketoconazole enhances efficacy of chemotherapy of experimental Chagas' disease

Journal of Antimicrobial Chemotherapy

Volumn 45, Issue 6, 2000, Pages 819-824

  Araujo M S S ^a,b   Martins Filho, O A ^b   Pereira, M E S ^b   Brener, Z ^b  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

BENZNIDAZOLE; KETOCONAZOLE; NIFURTIMOX; OFLOXACIN; OFLOXAN;

ANIMAL EXPERIMENT; ARTICLE; CHAGAS DISEASE; CONTROLLED STUDY; DERMATITIS; DIGESTIVE SYSTEM FUNCTION DISORDER; DRUG EFFICACY; DRUG SENSITIVITY; FEMALE; MOUSE; NEURITIS; NONHUMAN; POLYNEUROPATHY; TREATMENT OUTCOME; TRYPANOSOMA CRUZI; WEIGHT REDUCTION;

EID: 0343527887     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/45.6.819     Document Type: Article

References (27)

1. World Health Organization. (1996). Chagas Disease. Progress towards elimination of transmission. Weekly Epidemiological Record 71, 12-5.
2. Higuchi, M. L. (1995). Doença de Chagas. Importância do parasita na patogenia da forma crônica cardíaca. Arquivos Brasileiros de Cardiologia 64, 251-4.
3. Rezende, J. M. (1993). Manifestaçōes digestivas da Doença de Chagas. In Gastroenterologia Clinica, (Dani, R. & Castro, L. P., Eds), pp. 1729-55. Guanabara Koogan, Rio de Janeiro.
4. Schmunis, G. A., Zicker, F. & Moncayo, A. (1996). Interruption of Chagas' disease transmission through vector elimination. Lancet 348, 1171.
5. Cançado, J. R. (1985). Tratamento específico. In Cardiopatia Chagásica, (Cançado, J. R. & Chuster, M., Eds), pp. 327-55. Fundação Carlos Chagas, Belo Horizonte.
6. Ferreira, H. O. (1990). Tratamento da forma indeterminada da doença de Chagas com nifurtimox e benzonidazol. Revista da Sociedade Brasileira de Medicina Tropical 23, 209-11.
7. Galvão, L. M., Nunes, R. M., Cançado, J. R., Brener, Z. & Krettli, A. U. (1993). Lytic antibody titre as a means of assessing cure after treatment of Chagas disease: a 10 years follow-up study. Transactions of the Royal Society of Tropical Medicine and Hygiene 87, 220-3.
8. Brener, Z., Costa, C. A. & Chiari, C. (1976). Differences in the susceptibility of Trypanosoma cruzi strain to active chemotherapeutic agents. Revista do Instituto de Medicina tropical de São Paulo 18, 450-5.
9. Andrade, S. G., Magalhães, J. B. & Pontes, A. L. (1985). Evaluation of chemotherapy with benznidazole and nifurtimox in mice infected with Trypanosoma cruzi strains of different types. Bulletin of the World Health Organization 63, 721-6.
10. Filardi, L. S. & Brener, Z. (1987). Susceptibility and natural resistance of Trypanosoma cruzi strains to drugs used clinically in Chagas disease. Transactions of the Royal Society of Tropical Medicine and Hygiene 81, 755-9.
11. De Castro, S. L. (1993). The challenge of Chagas' disease chemotherapy: an update of drugs assayed against Trypanosoma cruzi. Acta Tropica 53, 83-98.
12. Urbina, J. A., Payares, G., Molina, J., Sanoja, C., Liendo, A., Lazardi, K. et al. (1996). Cure of short- and long-term experimental Chagas' disease using DO870. Science 273, 969-71.
13. McCabe, R. E., Araújo, F. G. & Remington, J. S. (1983). Ketoconazole protects against infection with Trypanosoma cruzi in a murine model. American Journal of Tropical Medicine and Hygiene 32, 960-2.
14. McCabe, R. E., Remington, J. S. & Araújo, F. G. (1984). Ketoconazole inhibition of intracellular multiplication of Trypanosoma cruzi and protection of mice against lethal infection with the organism. Journal of Infectious Diseases 150, 594-601.
15. Brener, Z., Cancado, J. R., Galvao, L. M., da Luz, Z. M., Filardi, L. de S., Pereira, M. E. et al. (1993). An experimental and clinical assay with ketoconazole in the treatment of Chagas' disease. Memórias do Instituto Oswaldo Cruz 88, 149-53.
16. Gonzales-Perdomo, M., De Castro, S. L., Meirelles, M. N, & Goldenberg, S. (1990). Trypanosoma cruzi proliferation and differentiation are blocked by topoisomerase II inhibitors. Antimicrobial Agents and Chemotherapy 34, 1707-14.
17. Pate, P. G., Wolfson, J. S., McHugh, G. L., Pan, S. C. & Swartz, M. N. (1986). Novobiocin antagonism of amastigotes of Trypanosoma cruzi growing in cell-free medium. Antimicrobial Agents and Chemotherapy 29, 426-31.
18. Chunge, C. N., Gachihi, G., Muigai, R., Wasunna, K., Rashida, J. R., Chulay, J. D. et al. (1985). Visceral leishmaniasis unresponsive to antimonial drugs. III. Successful treatment using a combination of sodium stibogluconate plus allopurinol. Transactions of the Royal Society of Tropical Medicine and Hygiene 79, 715-8.
19. Rosenthal, C. (1995). Resistência e uso combinado de drogas anti-HIV. Revista da Sociedade Brasileira de Medicina Tropical 28, Suppl. 2, 9-18.
20. Radloff, P. D., Philipps, J., Nkeyi, M., Hutchinson, D. & Kremsner, P. G. (1996). Atovaquone and proguanil for Plasmodium falciparum malaria. Lancet 347, 1511-4.
21. Urbina, J. A., Maldonado, R. A., Payares, G., Marchan, E., Lazardi, K., Aguirre, T. et al. (1991). In vitro and in vivo synergism of binary and ternary combinations of ergosterol biosynthesis inhibitors as antiproliferative agents against Trypanosoma cruzi: therapeutic implications. Memórias do Instituto Oswaldo Cruz 86, Suppl. 1, 33-5.
22. Brener, Z. & Chiari, E. (1963). Variações morfológicas observadas em diferentes amostras de Trypanosoma cruzi. Revista do Instituto de Medicina tropical de São Paulo 5, 220-4.
23. Pereira da Silva, L. H. & Nussenzweig, V. (1953). Sobre uma cepa de Trypanosoma cruzi altamente virulenta para camundongo branco. Folia Clinica et Biologica 20, 191-208.
24. Federici, E. E., Abelmann, W. H. & Neva, F. A. (1964). Chronic and progressive myocarditis in C3H mice infected with Trypanosoma cruzi. American Journal of Tropical Medicine and Hygiene 13, 272-80.
25. Filardi, L. S. (1975). Cryopreservation of Trypanosoma cruzi bloodstream forms. Journal of Protozoology 22, 398-401.
26. Brener, Z. (1962). Therapeutic activity and criterion of cure on mice experimentally infected with Trypanosoma cruzi. Revista do Instituto de Medicina tropical de São Paulo 4, 389-96.
27. Martins-Filho, O. A., Pereira, M. E., Carvalho, J. F. & Brener, Z. (1995). Flow cytometry, a new approach to detect anti-live trypomastigote antibodies and monitor the efficacy of specific treatment in human Chagas' Disease. Clinical and Diagnostic Laboratory Immunology 2, 569-73.